Plaintiffs Defeat Motion to Dismiss in Restasis Antitrust Litigation Against Allergan

Eye Drops

As reported in Law360 (subscription), plaintiffs in the multidistrict litigation against pharmaceutical manufacturer Allergan have successfully defeated a motion to dismiss the case alleging antitrust violations with respect to the sale and marketing of dry-eye drug Restasis. The Court’s ruling favored a group of pharmaceutical purchasers and union benefit plans accusing Allergan of misconduct intended to limit competition from generic drugs. [Read more…]